Predicted protein targets (top 18)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TSHR | P16473 | 3/20 | 0.62 |
| ▸ | CA12 | O43570 | 2/20 | 0.62 |
| ▸ | CA1 | P00915 | 2/20 | 0.62 |
| ▸ | CA2 | P00918 | 2/20 | 0.62 |
| ▸ | CA7 | P43166 | 2/20 | 0.62 |
| ▸ | CA9 | Q16790 | 2/20 | 0.62 |
| ▸ | NR5A1 | Q13285 | 1/20 | 0.61 |
| ▸ | TP53 | P04637 | 1/20 | 0.58 |
| ▸ | S1PR3 | Q99500 | 1/20 | 0.57 |
| ▸ | PLA2G4B | P0C869 | 2/20 | 0.57 |
| ▸ | NPC1 | O15118 | 1/20 | 0.55 |
| ▸ | RAB9A | P51151 | 1/20 | 0.55 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.55 |
| ▸ | RECQL | P46063 | 1/20 | 0.55 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.55 |
| ▸ | RARB | P10826 | 3/20 | 0.54 |
| ▸ | LTA4H | P09960 | 2/20 | 0.53 |
| ▸ | PLA2G4A | P47712 | 1/20 | 0.51 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4528116 | 1.00 | TSHR (0.62) | TSHRCA12CA1CA2CA7 | |
| SCHEMBL4539506 | 1.00 | TSHR (0.62) | TSHRCA12CA1CA2CA7 | |
| SCHEMBL4530059 | 1.00 | TSHR (0.62) | TSHRCA12CA1CA2CA7 | |
| SCHEMBL4524560 | 1.00 | TSHR (0.62) | TSHRCA12CA1CA2CA7 | |
| SCHEMBL4529708 | 1.00 | TSHR (0.62) | TSHRCA12CA1CA2CA7 | |
| SCHEMBL4533770 | 1.00 | TSHR (0.62) | TSHRCA12CA1CA2CA7 | |
| SCHEMBL4533781 | 1.00 | TSHR (0.62) | TSHRCA12CA1CA2CA7 | |
| SCHEMBL4527703 | 1.00 | TSHR (0.62) | TSHRCA12CA1CA2CA7 | |
| SCHEMBL4537643 | 1.00 | TSHR (0.62) | TSHRCA12CA1CA2CA7 | |
| SCHEMBL4531551 | 1.00 | TSHR (0.62) | TSHRCA12CA1CA2CA7 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2023069994-A1 | IMMUNOMODULATORS | BRISTOL-MYERS SQUIBB COMPANY (US) | 2023-04-27 | — | — | WO | disclosed |
| US-7534554-B2 | Chemically amplified resist composition and manufacturing method of semiconductor integrated circuit device with such chemically amplified resist composition | NEC ELECTRONICS CORPORATION (JP) | 2009-05-19 | — | — | US | disclosed |
| US-20080233518-A1 | CHEMICALLY AMPLIFIED RESIST COMPOSITION AND MANUFACTURING METHOD OF SEMICONDUCTOR INTEGRATED CIRCUIT DEVICE WITH SUCH CHEMICALLY AMPLIFIED RESIST COMPOSITION | NEC ELECTRONICS CORPORATION (JP) | 2008-09-25 | — | — | US | disclosed |
| US-7396633-B2 | Damascene process; forming connectors; exposure; development; using acid generator, quencher and buffer | NEC ELECTRONICS CORPORATION (JP) | 2008-07-08 | — | — | US | disclosed |
| US-20040259029-A1 | Chemically amplified resist composition and manufacturing method of semiconductor integrated circuit device with such chemically amplified resist composition | NEC ELECTRONICS CORPORATION (JP) | 2004-12-23 | — | — | US | disclosed |